http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2000894-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
| filingDate | 1989-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_745ea24ecd4e2f05121a5dc8c002c7c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_964aa1841dbe223cd0406120c1725857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e87f965e711e1a1915edad7d678622 |
| publicationDate | 1990-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2000894-A1 |
| titleOfInvention | Heterocyclic compounds |
| abstract | ABSTRACT HETEROCYCLIC COMPOUNDS Compounds are disclosed of formula (I) (I) wherein R1 represents hydrogen, unsubstituted or substituted C1-6alkyl, halogen, -COR4 or -CO2R4 (where R4 represents hydrogen or unsubstituted or substituted C1-6alkyl); R2 and R3 are the same or different and are C1-6alkyl or C3-6alkenyl; or -NR2R3 forms a 5-membered (optionally containing an oxygen atom adjacent to the nitrogen) or a 6-membered ring, which ring optionally contains one unit of unsaturation and which is unsubstituted or substituted by hydroxy, C1-6acyloxy, oxo, optionally substituted methylidene, -COR5 (where R5 represents C1-6alkyl, OR6 or -NHR6, and R6 represents hydrogen, C1-6alkyl, aryl, ar(C1-6)alkyl) or =NOR7 (where R7 represents C1-6alkyl); Z represents -O- or -S-; X represents a direct bond, -SH2- or -CH2O-; Ar represents a substituted phenyl moiety; and pharmaceutically acceptable salts thereof. The compounds are indicated as useful in the treatment of pain and cerebral ischaemia. Processes and intermediates for their preparation and pharmaceutical compositions containing them are also disclosed. |
| priorityDate | 1988-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.